Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Hair loss treatment caused more hair loss in a man.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Methotrexate and azathioprine can help treat alopecia areata.

A new therapy sped up wound healing and reduced scarring in diabetic rats.

The material combining eggshell protein and scaffold helps wounds heal faster and regenerates tissue effectively.

The new artificial derma is better for skin regeneration and biocompatibility.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

StemMACS media is better for growing therapeutic stem cells than PowerStem media.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Zinc supplements effectively treat acrodermatitis enteropathica.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

The hydrogel helps heal diabetic wounds faster by reducing inflammation.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Augmented virtual reality can help manage chronic skin conditions.

Hyaluronidase speeds up wound healing and reduces inflammation.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Arg1+ macrophages may play a role in causing alopecia areata.